Lymphocytes armed to kill: how customised cell engineering advances immunotherapy – Drug Target Review
Drug Target Review |
Lymphocytes armed to kill: how customised cell engineering advances immunotherapy
Drug Target Review The immune system is now regarded as a powerful weapon in the war against cancer, and in the current era immune cells have become ‘living drugs’. This review article considers some of the key advances in immuno-oncology… The idea that the immune … |
American Council on Science and Health |
Crispr created foods are different than GMOs, it is wrong for anti-GMO activists to pretend they’re not.
American Council on Science and Health Monsanto, perhaps to rebrand itself, and certainly to remain a leader in agricultural biotech has helped establish and fund Pairwise Plants a start-up using CRISPR-Cas9 technologies to modify seeds. They have given the new company money and their vice … Sweeter Strawberries With A Longer Shelf Life Could Be First Crispr OfferingsPerishableNews (press release) Enough With the Talking AlreadyGenomeWeb |
|
How CRISPR works, explained in two minutes
STAT We’ve traveled through time and space to bring back to life a hallowed surgical theater 3. We’ve followed sound waves 4 through our inner ears into our brains. Of all of these fantastic journeys, one of the hardest subjects to capture, visually, has … |
European Biotechnology |
Cellectis in offering of US$175m ADS following asset swap
European Biotechnology Cellectis’ CAR T platform use engineered T-cells from a healthy donor for use in multiple patients. This is distinct from autologous approaches that use a patient’s own T-cells to target tumor cells. Since manufacturing of autologous CAR T cell … |